Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Sep;14(9):601-18.
doi: 10.1038/nri3720.

A long-awaited merger of the pathways mediating host defence and programmed cell death

Affiliations
Review

A long-awaited merger of the pathways mediating host defence and programmed cell death

J Magarian Blander. Nat Rev Immunol. 2014 Sep.

Abstract

Historically, cell death and inflammation have been closely linked, but the necessary divergence of the fields in the past few decades has enriched our molecular understanding of the signalling pathways that mediate various programmes of cell death and multiple types of inflammatory responses. The fields have now come together again demonstrating a surprising level of integration. Intimate interconnections at multiple levels are revealed between the cell death and inflammatory signal transduction pathways that are mobilized in response to the engagement of pattern recognition receptors during microbial infection. Molecules such as receptor-interacting protein kinase 1 (RIPK1), RIPK3, FAS-associated death domain protein (FADD), FLICE-like inhibitory protein (FLIP) and caspase 8 - which are associated with different forms of cell death - are incorporated into compatible and exceedingly dynamic Toll-like receptor, NOD-like receptor and RIG-I-like receptor signalling modules. These signalling modules have a high capacity to switch from inflammation to cell death, or a programmed execution of both, all in an orchestrated battle for host defence and survival.

PubMed Disclaimer

References

    1. Cell Death Differ. 2002 Sep;9(9):981-94 - PubMed
    1. Immunobiology. 2013 Nov;218(11):1312-21 - PubMed
    1. J Immunol. 2009 Jul 15;183(2):787-91 - PubMed
    1. Mol Cell. 2014 Apr 10;54(1):133-146 - PubMed
    1. J Immunol. 2014 Aug 15;193(4):1539-1543 - PubMed

Publication types

MeSH terms

Substances